Global Health [MEDANTA] vs Aster DM Healthcare [ASTERDM] Detailed Stock Comparison
Global Health
NSE
Loading...
Aster DM Healthcare
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Global Health wins in 9 metrics, Aster DM Healthcare wins in 11 metrics, with 0 ties. Aster DM Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Global Health | Aster DM Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 70.43 | 95.09 | Global Health |
| Price-to-Book Ratio | 11.12 | 8.70 | Aster DM Healthcare |
| Debt-to-Equity Ratio | 21.19 | 55.26 | Global Health |
| PEG Ratio | 1.42 | -0.97 | Aster DM Healthcare |
| EV/EBITDA | 40.00 | 38.05 | Aster DM Healthcare |
| Profit Margin (TTM) | 13.83% | 7.55% | Global Health |
| Operating Margin (TTM) | 17.64% | 13.37% | Global Health |
| EBITDA Margin (TTM) | 17.64% | 13.37% | Global Health |
| Return on Equity | 14.21% | 147.28% | Aster DM Healthcare |
| Return on Assets (TTM) | 10.10% | 81.40% | Aster DM Healthcare |
| Free Cash Flow (TTM) | $-241.56M | $683.20M | Aster DM Healthcare |
| Dividend Yield | 0.04% | 1.05% | Aster DM Healthcare |
| 1-Year Return | 21.09% | 47.79% | Aster DM Healthcare |
| Price-to-Sales Ratio (TTM) | 9.74 | 7.36 | Aster DM Healthcare |
| Enterprise Value | $372.00B | $316.37B | Global Health |
| EV/Revenue Ratio | 9.63 | 7.51 | Aster DM Healthcare |
| Gross Profit Margin (TTM) | 76.81% | 77.07% | Aster DM Healthcare |
| Revenue per Share (TTM) | $144 | $84 | Global Health |
| Earnings per Share (Diluted) | $19.88 | $6.31 | Global Health |
| Beta (Stock Volatility) | -0.32 | 0.06 | Global Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Global Health vs Aster DM Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Global Health | -1.85% | -0.77% | 3.20% | 14.78% | 19.51% | 24.83% |
| Aster DM Healthcare | 1.11% | -0.24% | 1.61% | 11.10% | 49.16% | 15.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Global Health | 21.09% | 231.76% | 231.76% | 231.76% | 231.76% | 231.76% |
| Aster DM Healthcare | 47.79% | 160.14% | 368.65% | 248.23% | 248.23% | 248.23% |
Performance & Financial Health Analysis: Global Health vs Aster DM Healthcare
| Metric | MEDANTA | ASTERDM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹376.24B | ₹310.19B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 329,855 | 807,482 |
| 90 Day Avg. Volume | 423,799 | 795,182 |
| Last Close | ₹1,374.00 | ₹601.05 |
| 52 Week Range | ₹935.50 - ₹1,456.50 | ₹387.10 - ₹675.00 |
| % from 52W High | -5.66% | -10.96% |
| All-Time High | ₹1,513.90 (Feb 12, 2024) | ₹675.00 (Jul 03, 2025) |
| % from All-Time High | -9.24% | -10.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.08% |
| Quarterly Earnings Growth | 0.50% | -0.98% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.08% |
| Operating Margin (TTM) | 0.18% | 0.13% |
| Return on Equity (TTM) | 0.14% | 1.47% |
| Debt to Equity (MRQ) | 21.19 | 55.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹125.91 | ₹68.98 |
| Cash per Share (MRQ) | ₹41.79 | ₹26.98 |
| Operating Cash Flow (TTM) | ₹5.45B | ₹54.10B |
| Levered Free Cash Flow (TTM) | ₹4.81B | ₹53.78B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.04% | 1.05% |
| Last 12-Month Dividend | ₹0.50 | ₹6.00 |
Valuation & Enterprise Metrics Analysis: Global Health vs Aster DM Healthcare
| Metric | MEDANTA | ASTERDM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 70.43 | 95.09 |
| Forward P/E | 59.81 | 63.76 |
| PEG Ratio | 1.42 | -0.97 |
| Price to Sales (TTM) | 9.74 | 7.36 |
| Price to Book (MRQ) | 11.12 | 8.70 |
| Market Capitalization | ||
| Market Capitalization | ₹376.24B | ₹310.19B |
| Enterprise Value | ₹372.00B | ₹316.37B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.63 | 7.51 |
| Enterprise to EBITDA | 40.00 | 38.05 |
| Risk & Other Metrics | ||
| Beta | -0.32 | 0.06 |
| Book Value per Share (MRQ) | ₹125.91 | ₹68.98 |
Financial Statements Comparison: Global Health vs Aster DM Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MEDANTA | ASTERDM |
|---|---|---|
| Revenue/Sales | ₹10.31B | ₹10.78B |
| Cost of Goods Sold | ₹2.39B | ₹2.47B |
| Gross Profit | ₹7.92B | ₹8.31B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹1.82B | ₹1.44B |
| EBITDA | ₹2.47B | ₹2.35B |
| Pre-Tax Income | ₹2.08B | ₹1.36B |
| Income Tax | ₹491.59M | ₹428.80M |
| Net Income (Profit) | ₹1.59B | ₹935.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MEDANTA | ASTERDM |
|---|---|---|
| Cash & Equivalents | ₹2.30B | ₹1.65B |
| Total Current Assets | ₹15.33B | ₹19.01B |
| Total Current Liabilities | ₹6.19B | ₹8.79B |
| Long-Term Debt | ₹6.24B | ₹18.29B |
| Total Shareholders Equity | ₹33.88B | ₹36.51B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹25.08B | ₹36.28B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MEDANTA | ASTERDM |
|---|---|---|
| Operating Cash Flow | ₹1.40B | N/A |
| Capital Expenditures | ₹-661.90M | N/A |
| Free Cash Flow | ₹828.74M | N/A |
| Debt Repayment | ₹71.87M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MEDANTA | ASTERDM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 329,855 | 807,482 |
| Average Daily Volume (90 Day) | 423,799 | 795,182 |
| Shares Outstanding | 268.59M | 498.21M |
| Float Shares | 87.13M | 185.59M |
| % Held by Insiders | 0.68% | 0.52% |
| % Held by Institutions | 0.21% | 0.32% |
Dividend Analysis & Yield Comparison: Global Health vs Aster DM Healthcare
| Metric | MEDANTA | ASTERDM |
|---|---|---|
| Last 12-Month Dividend | ₹0.50 | ₹6.00 |
| Last 12-Month Dividend Yield | 0.04% | 1.05% |
| 3-Year Avg Annual Dividend | ₹0.17 | ₹41.33 |
| 3-Year Avg Dividend Yield | 0.04% | 11.45% |
| 3-Year Total Dividends | ₹0.50 | ₹124.00 |
| Ex-Dividend Date | Aug 22, 2025 | Feb 10, 2025 |